MOSAIC IMMUNOENGINEERING, INC.: 10-Q filed 2017-04-13

Name: MOSAIC IMMUNOENGINEERING, INC.: 10-Q filed 2017-04-13
Creator: MOSAIC IMMUNOENGINEERING, INC.

What MOSAIC IMMUNOENGINEERING, INC. reported in its quarterly report filed 2017-04-13 (fiscal Q3 2017): 24 published measures, 68 facts as tagged in accession 0001683168-17-000916.

This filing

Form: 10-Q (quarterly report)
Filed: 2017-04-13
Fiscal period: fiscal Q3 2017
Accession: 0001683168-17-000916 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All MOSAIC IMMUNOENGINEERING, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2017-02-28	4,090,780	USD
At 2016-05-31	3,823,344	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2017-02-28	58,915	USD
At 2016-05-31	73,512	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2017-02-28	4,031,865	USD
At 2016-05-31	3,749,832	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2017-02-28	1,815,707	USD
At 2016-05-31	1,159,576	USD
At 2016-02-29	1,519,157	USD
At 2015-05-31	2,679,360	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2016-12-01 to 2017-02-28	-309,323	USD	90
2016-06-01 to 2017-02-28	282,033	USD	273
2015-12-01 to 2016-02-29	-531,865	USD	91
2015-06-01 to 2016-02-29	-693,515	USD	274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2016-06-01 to 2017-02-28	2,703	USD	273
2015-06-01 to 2016-02-29	0	USD	274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2017-02-28	-58,790,711	USD
At 2016-05-31	-59,072,744	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2016-12-01 to 2017-02-28	398,548,318	shares	90
2016-06-01 to 2017-02-28	398,548,318	shares	273
2015-12-01 to 2016-02-29	398,548,318	shares	91
2015-06-01 to 2016-02-29	398,548,318	shares	274

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2016-12-01 to 2017-02-28	398,548,318	shares	90
2016-06-01 to 2017-02-28	401,398,948	shares	273
2015-12-01 to 2016-02-29	398,548,318	shares	91
2015-06-01 to 2016-02-29	398,548,318	shares	274

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Unit	Days
2016-12-01 to 2017-02-28	USD/shares	90
2016-06-01 to 2017-02-28	USD/shares	273
2015-12-01 to 2016-02-29	USD/shares	91
2015-06-01 to 2016-02-29	USD/shares	274

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Unit	Days
2016-12-01 to 2017-02-28	USD/shares	90
2016-06-01 to 2017-02-28	USD/shares	273
2015-12-01 to 2016-02-29	USD/shares	91
2015-06-01 to 2016-02-29	USD/shares	274

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2016-12-01 to 2017-02-28	0	USD	90
2016-06-01 to 2017-02-28	2,400	USD	273
2015-12-01 to 2016-02-29	0	USD	91
2015-06-01 to 2016-02-29	2,400	USD	274

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2017-02-28	2,102	USD
At 2016-05-31	0	USD

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2017-02-28	3,391,592	USD
At 2016-05-31	3,152,578	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2017-02-28	58,915	USD
At 2016-05-31	73,512	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2017-02-28	7,717	USD
At 2016-05-31	33,215	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2016-12-01 to 2017-02-28	281,265	USD	90
2016-06-01 to 2017-02-28	887,881	USD	273
2015-12-01 to 2016-02-29	405,242	USD	91
2015-06-01 to 2016-02-29	1,145,606	USD	274

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Period	Value	Unit	Days
2016-12-01 to 2017-02-28	281,265	USD	90
2016-06-01 to 2017-02-28	887,881	USD	273
2015-12-01 to 2016-02-29	405,242	USD	91
2015-06-01 to 2016-02-29	1,145,606	USD	274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2017-02-28	401,392,948	shares
At 2016-05-31	401,392,948	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2017-02-28	77,444,062	USD
At 2016-05-31	77,444,062	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2017-02-28	51,198	USD
At 2016-05-31	40,297	USD

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2016-06-01 to 2017-02-28	601	USD	273
2015-06-01 to 2016-02-29	1,237	USD	274

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2016-12-01 to 2017-02-28	-28,058	USD	90
2016-06-01 to 2017-02-28	1,172,314	USD	273
2015-12-01 to 2016-02-29	-126,623	USD	91
2015-06-01 to 2016-02-29	454,491	USD	274

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

Period	Value	Unit	Days
2016-06-01 to 2017-02-28	2,300	USD	273
2015-06-01 to 2016-02-29	0	USD	274

Inspect the source

Entity: MOSAIC IMMUNOENGINEERING, INC. / CIK 0000836564
Captured: 2026-09-19T15:08:56.564Z
SEC response SHA-256: 20b7dbddee8b1aee5cb56cb4cf5c3c14c36ef1fafb538ec0211cfb2585ddf3fd

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000836564.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))